2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow sovateltide: new trials by email Literature Review of sovateltide trials Research Report on sovateltide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC) SPI-1620, Docetaxel - Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Terminated | Spectrum Pharmaceuticals, Inc | 34 | 2013-05-01 | 2021-10-13 |
| Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer SPI-1620, Docetaxel - Biliary Cancer | Phase 2 | Terminated | Spectrum Pharmaceuticals, Inc | 30 | 2013-04-01 | 2021-10-13 |
Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1)
Spectrum Pharmaceuticals, Inc (2)
United States (2)